Effects of Tamiflu still uncertain, warn experts, as Roche continues to withhold key trial data
Two years after pharmaceutical giant Roche promised the BMJ it would release key Tamiflu trial data for independent scrutiny, the safety and effectiveness of this anti-influenza drug remains uncertain, warn experts today. ...
Medications
Jan 18, 2012 |
not rated yet |
0
|
Specific antipsychotic drugs increase risk of death in elderly dementia patients
Nursing home residents over the age of 65 who take certain antipsychotic medication for dementia are at an increased risk of death, suggests a research paper published today in the British Medical Journal.
Medications
Feb 23, 2012 |
5 / 5 (1) |
0
|
Pot-based prescription drug looks for FDA OK
A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by ...
Medications
Jan 23, 2012 |
not rated yet |
0
US OKs first-of-its-kind diabetes drug (Update)
The U.S. Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar—flushing it out in patients' urine.
Medications
Mar 29, 2013 |
not rated yet |
0
Some drugs are going generic this year and next
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations ...
Medications
Aug 03, 2012 |
5 / 5 (1) |
1
No anthrax vaccine testing on children -- for now
Should the anthrax vaccine be tested in children? It will be a while longer before the government decides.
Medications
Oct 29, 2011 |
not rated yet |
1
India's global pharmacy role threatened by EU pact
(AP) -- Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted ...
Medications
Feb 10, 2012 |
not rated yet |
0
US court rejects bid to reclassify marijuana (Update 2)
A U.S. appeals court Tuesday rejected a petition to reclassify marijuana from its current federal status as a dangerous drug with no accepted medical use.
Medications
Jan 22, 2013 |
not rated yet |
1
Aspirin may temper brain power decline in elderly women at risk of heart disease
Daily low dose aspirin could slow the decline in brain power among elderly women at high risk of heart disease, indicates observational research published in the online journal BMJ Open.
Medications
Oct 03, 2012 |
not rated yet |
0
Pfizer recalls 1 million packets of US birth control pills
US pharmaceutical giant Pfizer on Wednesday recalled one million packets of birth control pills over a packaging error that could put women at risk of unintended pregnancy.
Medications
Feb 01, 2012 |
not rated yet |
1
New European pill works against uterine fibroids
New research offers hope for the first pill to treat a common problem in young women: fibroids in the uterus. The growths can cause pain, heavy bleeding and fertility problems, and they are the leading cause of hysterectomies.
Medications
Feb 02, 2012 |
4.5 / 5 (2) |
0
Research examines effects of opioids on patients with sickle cell disease
Researchers from Virginia Commonwealth University (VCU) sought to shed light on the biopsychosocial and spiritual effects of taking prescribed opioids to treat noncancer pain. Such questions have received little examination ...
Medications
Apr 11, 2013 |
not rated yet |
0
Plavix's new generic status could be boon for patients
(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.
Medications
May 15, 2012 |
not rated yet |
0
HPV vaccine trends point to failures in patient education, vaccine programs
Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public ...
Medications
Mar 14, 2013 |
5 / 5 (1) |
0
FDA outlines path for lower-priced biotech drugs
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.
Medications
Feb 09, 2012 |
not rated yet |
1
